(Guan Media Editorial Center)[Reporter Guo Jia/Comprehensive Report]According to statistics from the Ministry of Health and Welfare, cancer has ranked first among the top ten causes of death in the country for 41 consecutive years, and the latest data points out that the number of cancer deaths in 2011 has increased compared with last year. 271 people, rising to 51,927. In addition, many people have stopped cancer screening due to the impact of the epidemic, which has also made the Chinese people more afraid of cancer. In addition to needing to be extra vigilant, they also look forward to cancer treatment. On the other hand, these patients can be given medical help through new treatments.
▲ Picture: Dr. Liu Bingzhong, convener and executive physician of the Cell Therapy Center of Banqiao Zhongxing Hospital and chief medical officer of Luke Biomedical, has been committed to cancer treatment for many years and helps patients reduce recurrence and extend life span through immune cell therapy.
Advertisement (Please continue reading this article)
Dr. Liu Bing, the convener and executive physician of the Cell Therapy Center of Banqiao Zhongxing Hospital, has been committed to cancer treatment for many years. In the face of traditional treatments, Dr. Liu Bing pointed out two key shortcomings, such as drug resistance and side effects. For example, It is said that, such as chemotherapy and targeted therapy, the initial tumor will be controlled, but the subsequent side effects and drug resistance will cause a bottleneck in subsequent cancer treatment. In order to improve the survival rate of cancer patients, restore patients’ health and prevent cancer recurrence, Luke Biomedical is committed to developing high-efficiency cancer cell therapy technology “immune cell therapy”.
As for what is “immune cell therapy”? Liu Bing, a Chinese medicine doctor, explained that autologous immune cell therapy is a mild treatment method with no side effects. Lujia Biomedical’s cancer cell therapy technology comes from the Japanese company LYMPHOTEC, which was founded by the director of the laboratory of the National Cancer Center of Japan. It is mainly By copying and cultivating memory T cells in the body, these memory T cells are, metaphorically speaking, specific, like special police officers, able to identify tumor cells and destroy them.
For example, Dr. Liu Bing of Traditional Chinese Medicine once encountered a 60-year-old woman with colorectal cancer in clinical practice. The colorectal cancer recurred after surgery and was found to be accompanied by lung metastasis. After the lungs were electrically cauterized, the lung tumor recurred within half a year. After immune cell therapy, tumor necrosis and scabbing recurred in the lungs. It has been more than a year of follow-up period, and the recovery status is good with no recurrence. There is another case of a gentleman with stage IV liver cancer metastasis and intrahepatic cholangiocarcinoma. When he came here, the tumor in his liver was already 8 centimeters in size. It had obviously compressed other important organs and seriously affected his life. After coming for consultation and combined with memory T cell therapy, the tumor completely disappeared and she is currently recovering well.
Advertisement (Please continue reading this article)
Dr. Liu Bing also emphasized that in clinical practice, all solid cancers can be treated with this type of immune cell therapy, such as nasopharyngeal cancer, lung cancer, colorectal cancer, glial cancer, pancreatic cancer, and even breast cancer, etc. Immune cell therapy can be used to reduce the recurrence rate of cancer and extend the life of patients.
The doctor also mentioned that autologous immune cell therapy like this has been used in Japan for many years, and has been approved for use in South Korea. The Lujia Biomedical Team has built a Xizhi GTP cell preparation site. Banqiao Zhongxing Hospital and Lujia Biomedicine applied to the Ministry of Health and Welfare for a special-regulation cell therapy entrustment plan and were successfully approved. They can perform autologous immune cell therapy for patients. In the future, they will be able to provide patients with more effective cancer treatments without side effects. treatment.
2023-11-13 16:36:32
#Dont #panic #cancer #Physicians #evidence #Immune #cell #therapy #reduces #recurrence #rate #extends #lifespan #Guan #Media #LINE #TODAY
